Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test

Tytuł:
Intestinal current measurement and nasal potential difference to make a diagnosis of cases with inconclusive CFTR genetics and sweat test
Autorzy:
Tobias Welte
Rebecca Minso
Angela Schulz
Christian Dopfer
Nadine Alfeis
Andrea van Barneveld
Lena Makartian-Gyulumyan
Gesine Hansen
Sibylle Junge
Carsten Müller
Felix C C Ringshausen
Annette Sauer-Heilborn
Frauke Stanke
Cornelia Stolpe
Stephanie Tamm
Anna-Maria Dittrich
Burkhard Tümmler
Temat:
Medicine
Diseases of the respiratory system
RC705-779
Źródło:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Wydawca:
BMJ Publishing Group, 2020.
Rok publikacji:
2020
Kolekcja:
LCC:Medicine
LCC:Diseases of the respiratory system
Typ dokumentu:
article
Opis pliku:
electronic resource
Język:
English
ISSN:
2052-4439
Relacje:
https://bmjopenrespres.bmj.com/content/7/1/e000736.full; https://doaj.org/toc/2052-4439
DOI:
10.1136/bmjresp-2020-000736
Dostęp URL:
https://doaj.org/article/064282ba84d44b75846a572f39987840  Link otwiera się w nowym oknie
Numer akcesji:
edsdoj.064282ba84d44b75846a572f39987840
Czasopismo naukowe
Background Nasal potential difference (NPD) and intestinal current measurements (ICM) are cystic fibrosis transmembrane conductance regulator (CFTR) biomarkers recommended to make a diagnosis in individuals with inconclusive sweat test and CFTR genetics and a clinical suspicion for cystic fibrosis (CF) or CFTR-related disorder (CFTR-RD).Methods NPD and ICM were measured according to standard operating procedures of the European Cystic Fibrosis Society Diagnostic Network Working Group.Results We assessed 219 individuals by NPD or ICM who had been referred to our laboratory due to clinical symptoms suggestive of CF, but inconclusive sweat test and CFTR genetics (median age: 16.3 years, range 0.4 to 76 years). CF or CFTR-related disorder was diagnosed in 22 of 29 patients (76%) with a CFTR genotype of unknown or variable clinical significance and in 51 of 190 carriers (27%) of one (35/42) or no (16/148) identified CFTR mutation. If two CFTR sequence variants had been identified, the outcome of NPD and ICM was consistent with the classification of the CFTR2 database. Moreover, a suspected false-positive diagnosis of CF was confirmed in seven and withdrawn in eight patients. Of 26 individuals assessed by both NPD and ICM, eleven individuals exhibited discordant tracings of ICM and NPD, with one measurement being in the CF range and the other in the normal range.Conclusion The majority of patients whom we diagnosed with CF or CFTR-RD by extended electrophysiology are carriers of the wild-type CFTR coding sequence on at least one of their CF alleles. The disease-causing genetic lesions should reside in the non-coding region of CFTR or elsewhere in the genome, affecting the regulation of CFTR expression in a tissue-depending fashion which may explain the large within-group variability of CFTR activity in the respiratory and intestinal epithelium seen in this group.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies